 | • レポートコード：MRC-IM30026 • 出版社/出版日：IMARC / 2022年10月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年に2,980億ドルであった世界のタンパク質治療薬市場規模が、2022年から2027年の間にCAGR 7.26％で成長し、2027年までに4,560億ドルに達すると予測しています。本調査レポートでは、タンパク質治療薬の世界市場について総合的に調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別（モノクローナル抗体（mAb）、ヒトインスリン、エリスロポエチン、凝固因子、融合タンパク質）分析、治療領域別（代謝障害、免疫疾患、血液疾患、癌、ホルモン疾患）分析、機能別（酵素＆調節活動、対象特化活動、ワクチン、タンパク質診断）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目をまとめています。なお、本書に掲載されている企業情報には、Amgen Inc., Abbott Laboratories, Abbvie Inc., Baxter International Inc., Biogen Inc., Csl Behring L.L.C. (CSL Limited), Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding AG), Johnson & Johnson, Merck & Co. Inc., Novo Nordisk A/S (Novo Holdings A/S)などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のタンパク質治療薬市場規模：製品別 - モノクローナル抗体（mAb）の市場規模 - ヒトインスリンの市場規模 - エリスロポエチンの市場規模 - 凝固因子の市場規模 - 融合タンパク質の市場規模 ・世界のタンパク質治療薬市場規模：治療領域別 - 代謝障害における市場規模 - 免疫疾患における市場規模 - 血液疾患における市場規模 - 癌における市場規模 - ホルモン疾患における市場規模 ・世界のタンパク質治療薬市場規模：機能別 - 酵素＆調節活動の市場規模 - 対象特化活動の市場規模 - ワクチンの市場規模 - タンパク質診断の市場規模 ・世界のタンパク質治療薬市場規模：地域別 - 北米のタンパク質治療薬市場規模 - アジアのタンパク質治療薬市場規模 - 欧州のタンパク質治療薬市場規模 - 中南米のタンパク質治療薬市場規模 - 中東・アフリカのタンパク質治療薬市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global protein therapeutics market size reached US$ 298.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 456.0 Billion by 2027, exhibiting a growth rate (CAGR) of 7.26% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Protein therapeutics refers to artificially synthesized protein-based medicines. They are fast-acting, potent medicines that deliver small protein molecules to the body in a specific amount. They usually consist of recombinant forms of naturally occurring proteins, such as monoclonal antibodies, insulin, fusion proteins, erythropoietin, interferon, human growth hormones (HGH) and follicle-stimulating hormones. They aid in treating chronic medical ailments, such as cancer, diabetes, neurodegenerative disorders and immunological, hematological, hormonal and genetic disorders. Various combination therapy drugs are also used with protein therapeutics that can be inhaled, injected or orally administered.
Global Protein Therapeutics Market Trends and Drivers:
The increasing prevalence of chronic medical ailments is one of the key factors driving the growth of the protein therapeutics market. In line with this, the rising awareness among the masses regarding the benefits of protein therapeutics, such as minimal risks of side effects and high efficiency, are contributing to the market growth. Monoclonal antibodies are being widely researched and used for the treatment of various viral and bacterial diseases and pharmaceutical companies are using protein therapeutics for drug discovery and development. The sudden outbreak of the coronavirus disease (COVID-19) is further providing growth opportunities to market players. For instance, Molecular Partners AG, a Switzerland-based clinical stage biotechnology company, is developing a new class of protein therapeutics, called DARPin®, to inhibit the proliferation of the virus.
The development of novel recombinant proteins, peptides, antibody-based drugs and plasma proteins is acting as other-growth inducing factors. These protein therapeutics are extensively used in replacement therapies to treat genetic and autoimmune disorders, such as dysfibrinogenemia, afibrinogenemia, and hypofibrinogenemia. Other factors, including extensive research and development (R&D) activities in the field of protein engineering, along with significant improvements in the healthcare infrastructure, are expected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global protein therapeutics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, therapy area and function.
Breakup by Product:
Monoclonal Antibodies (mAbs)
Human Insulin
Erythropoietin
Clotting Factors
Fusion Protein
Others
Breakup by Therapy Area:
Metabolic Disorders
Immunological Disorders
Hematological Disorders
Cancer
Hormonal Disorders
Genetic Disorders
Others
Breakup by Function:
Enzymatic and Regulatory Activity
Special Targeting Activity
Vaccines
Protein Diagnostics
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Amgen Inc., Abbott Laboratories, Abbvie Inc., Baxter International Inc., Biogen Inc., Csl Behring L.L.C. (CSL Limited), Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding AG), Johnson & Johnson, Merck & Co. Inc., Novo Nordisk A/S (Novo Holdings A/S) and Pfizer Inc.
Key Questions Answered in This Report:
How has the global protein therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global protein therapeutics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the therapy area?
What is the breakup of the market based on the function?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global protein therapeutics market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Protein Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Monoclonal Antibodies (mAbs)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Human Insulin
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Erythropoietin
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Clotting Factors
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Fusion Protein
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Therapy Area
7.1 Metabolic Disorders
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Immunological Disorders
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Hematological Disorders
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cancer
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Hormonal Disorders
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Genetic Disorders
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Function
8.1 Enzymatic and Regulatory Activity
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Special Targeting Activity
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Vaccines
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Protein Diagnostics
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Amgen Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Abbott Laboratories
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Abbvie Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Baxter International Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Biogen Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Csl Behring L.L.C. (CSL Limited)
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Eli Lilly and Company
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 F. Hoffmann-La Roche AG (Roche Holding AG)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Johnson & Johnson
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Merck & Co. Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Novo Nordisk A/S (Novo Holdings A/S)
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Pfizer Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
Figure 2: Global: Protein Therapeutics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Protein Therapeutics Market: Breakup by Product (in %), 2021
Figure 4: Global: Protein Therapeutics Market: Breakup by Therapy Area (in %), 2021
Figure 5: Global: Protein Therapeutics Market: Breakup by Function (in %), 2021
Figure 6: Global: Protein Therapeutics Market: Breakup by Region (in %), 2021
Figure 7: Global: Protein Therapeutics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 8: Global: Protein Therapeutics (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Protein Therapeutics (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Protein Therapeutics (Human Insulin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Protein Therapeutics (Human Insulin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Protein Therapeutics (Erythropoietin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Protein Therapeutics (Erythropoietin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Protein Therapeutics (Clotting Factors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Protein Therapeutics (Clotting Factors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Protein Therapeutics (Fusion Protein) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Protein Therapeutics (Fusion Protein) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Protein Therapeutics (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Protein Therapeutics (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Protein Therapeutics (Metabolic Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Protein Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Protein Therapeutics (Immunological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Protein Therapeutics (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Protein Therapeutics (Hematological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Protein Therapeutics (Hematological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Protein Therapeutics (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Protein Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Protein Therapeutics (Hormonal Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Protein Therapeutics (Hormonal Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Protein Therapeutics (Genetic Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Protein Therapeutics (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Protein Therapeutics (Other Therapy Areas) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Protein Therapeutics (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Protein Therapeutics (Enzymatic and Regulatory Activity) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Protein Therapeutics (Enzymatic and Regulatory Activity) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Protein Therapeutics (Special Targeting Activity) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Protein Therapeutics (Special Targeting Activity) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Protein Therapeutics (Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Protein Therapeutics (Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Protein Therapeutics (Protein Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Protein Therapeutics (Protein Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: North America: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: North America: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: United States: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: United States: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Canada: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Canada: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Asia Pacific: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Asia Pacific: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: China: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: China: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Japan: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Japan: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: India: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: India: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: South Korea: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: South Korea: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Australia: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Australia: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Indonesia: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Indonesia: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Others: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Others: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Europe: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Europe: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Germany: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Germany: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: France: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: France: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: United Kingdom: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: United Kingdom: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Italy: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Italy: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Spain: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Spain: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Russia: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Russia: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Others: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Others: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Latin America: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Latin America: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Brazil: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Brazil: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Mexico: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Mexico: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Others: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Others: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Middle East and Africa: Protein Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: Middle East and Africa: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Global: Protein Therapeutics Industry: SWOT Analysis
Figure 91: Global: Protein Therapeutics Industry: Value Chain Analysis
Figure 92: Global: Protein Therapeutics Industry: Porter’s Five Forces Analysis
• 日本語訳：タンパク質治療薬の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30026 ▷ お問い合わせ（見積依頼・ご注文・質問）